By Editorial team · Published · Last updated
Healthtech startups face a two-framework problem on a startup budget. Here's a phased compliance roadmap from first enterprise sale to health system procurement.
Most healthtech startups hit the same wall: an enterprise customer wants both a SOC 2 report and a signed Business Associate Agreement before onboarding, but the startup has neither. The instinct is to treat HIPAA and SOC 2 as separate projects with separate budgets. That instinct is wrong — the right approach is a single integrated program that satisfies both requirements with shared controls and shared evidence.
Enterprise health system IT security teams vary significantly in their requirements. Smaller regional hospitals may accept a SOC 2 Type I and a BAA. Mid-size health systems typically require a SOC 2 Type II. Large IDNs (Integrated Delivery Networks) and academic medical centers are increasingly requiring HITRUST CSF or, at minimum, a SOC 2 Type II with documented HIPAA mapping. Federal health agencies (VA, CMS, Indian Health Service) have their own additional requirements (FedRAMP, NIST SP 800-53) that go beyond SOC 2.
For a seed or pre-Series A healthtech startup, the goal of the first compliance program cycle is to unblock sales, not to achieve the highest possible compliance bar. A SOC 2 Type I combined with a properly executed BAA satisfies early enterprise customers and allows the company to learn what its actual control gaps are before committing to a full Type II observation period.
Begin Type II observation immediately after Type I issuance. A 3-month observation window is acceptable for the first Type II. Add the Privacy TSC (P1 through P8) if your product processes ePHI — this demonstrates tested privacy controls rather than self-attested HIPAA compliance, which enterprise security teams increasingly distinguish.
Key controls for the Privacy TSC in a healthtech context: consent management for ePHI use, data subject access request procedures (patients can request their data under HIPAA), data retention and deletion schedules aligned with HIPAA's minimum necessary standard, and privacy incident response procedures separate from security incident response.
Qualifying criteria: documented health data or digital health client portfolio, ability to add HIPAA mapping notes to the SOC 2 report, and familiarity with EHR integrations (HL7/FHIR) as a technical surface in the system description. Prescient Assurance, BARR Advisory, and Johanson Group have publicly documented health sector experience. For Series A healthtech companies, budget $20K–$50K for a combined SOC 2 Type II + HIPAA documentation program in the first year.
GRC platforms with dedicated HIPAA modules let healthtech teams manage SOC 2 and HIPAA evidence in a single system rather than two parallel spreadsheets. Vanta and Drata both offer HIPAA modules that map controls to the HIPAA Security Rule safeguards alongside the SOC 2 Trust Services Criteria. Sprinto has a similar offering at a lower price point for earlier-stage companies. The key capability to verify before selecting a platform: does the platform track BAA status for subprocessors? A BAA tracker reduces the risk of onboarding a new SaaS tool that handles ePHI without executing the required agreement.
One practical note on platform ROI for healthtech: the evidence collection automation that justifies a GRC platform subscription is more valuable when you're running two frameworks (SOC 2 + HIPAA) than one. The marginal cost of adding HIPAA coverage within an existing platform subscription is low. Running HIPAA compliance manually while using a GRC platform for SOC 2 is a common mistake that doubles the documentation workload for no incremental cost savings.